Skip to main content
HCONRES 30 108th Congress House Health Autoimmune diseases Commemorations Communication in medicine Communication in science Conferences Congress Congressional tributes Economics and Public Finance Environmental Protection Environmental research Environmentally induced diseases Epidemiology Federal aid to research Genetic research Genetics Government Operations and Politics Health education Medical research Prescription pricing

Expressing the sense of the Congress regarding scleroderma.

Introduced: February 5, 2003 See on congress.gov
This resolution expired with the 108th Congress
It was not agreed to before the 108th Congress (2003–2004) adjourned, so it is no longer active. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
Feb 14, 2003
Referred to the Subcommittee on Health.
Feb 6, 2003
Sponsor introductory remarks on measure. (CR E139)
Feb 5, 2003
Referred to the House Committee on Energy and Commerce.
Feb 5, 2003
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service
Calls for: (1) recognition of private organizations and health care providers for promoting awareness of and research on scleroderma; (2) greater awareness of the symptoms of scleroderma and contributions to the fight against it; (3) the Government to promote awareness, to adequately fund scleroderma research projects, and to continue to consider ways to improve the quality of health care services for scleroderma patients; (4) the National Institutes of Health to continue to play a leadership role in the fight against scleroderma; and (5) the Centers for Disease Control and Prevention to give priority to establishing a national epidemiological study to better track and gather information about scleroderma.
What's happening now February 14, 2003

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H. Con. Res. 30: Expressing the sense of the Congress regarding scleroderma.. 108th Congress. Open America. https://openamerica.io/bill/108-HCONRES-30/
MLA
"H. Con. Res. 30: Expressing the sense of the Congress regarding scleroderma.." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HCONRES-30/.
Bluebook (legal)
H. Con. Res. 30, 108th Cong. (2026), https://openamerica.io/bill/108-HCONRES-30/.
Markdown link
[H. Con. Res. 30: Expressing the sense of the Congress regarding scleroderma.](https://openamerica.io/bill/108-HCONRES-30/)
Report a problem